Skip to main content
TheraVet SA logo

TheraVet SA — Investor Relations & Filings

Ticker · ALVET ISIN · BE0974387194 LEI · 984500804EBR3F1EFF71 BR Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2021-11-03 M&A Activity
Country BE Belgium
Listing BR ALVET

About TheraVet SA

https://www.egeiro.com/

TheraVet SA is a veterinary biotechnology company specializing in the development and commercialization of treatments for osteoarticular diseases in companion animals. The company focuses on creating a portfolio of pharmaceutical products and solutions designed to manage bone and joint conditions, such as osteoarthritis. Its primary objective is to provide innovative therapeutic options to improve the mobility and quality of life for pets.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
M&A Activity Classification · 99% confidence The document is a press release dated November 3, 2021, announcing the renewal and extension of an exclusive worldwide license between TheraVet and Graftys, specifically adding a new injectable bone substitute to TheraVet's portfolio. This announcement details a business development/partnership expansion and product line enhancement. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a corporate announcement regarding business operations and strategy, which fits best under the general category of corporate news or regulatory filings that don't fit elsewhere. Given the options, since it is a specific corporate announcement about a business deal and product expansion, and not a standard financial report, it most closely aligns with a general regulatory announcement or news release. Since there isn't a specific 'Business Development' code, 'RNS' (Regulatory Filings - general regulatory announcements and fallback category) is the most appropriate fit for a press release detailing a significant operational/licensing update that is not explicitly covered by other codes like DIV, CAP, or M&A (TAR). The length is short (3708 chars), suggesting it's an announcement rather than a full report.
2021-11-03 French
Inside Information / Other news releases
Environmental & Social Information Classification · 99% confidence The document is explicitly labeled as a "PRESS RELEASE – Inside Information – Regulated Information". It announces a specific business event: the renewal and extension of an exclusive worldwide license with Graftys and the addition of a new injectable bone substitute product to TheraVet's portfolio. This type of announcement, which conveys material, non-public information to the market, fits best under the general category of regulatory announcements or specific corporate actions. Since it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific shareholder vote result (DVA), it falls into the category for general regulatory disclosures. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a standard, regulated press release containing material business updates that don't fit a more specific category like M&A (TAR) or Capital Change (CAP). The document length (3398 chars) is short, suggesting it is an announcement rather than a comprehensive report.
2021-11-03 English
Rapport Financier Semestriel_30 Juin 2021_ TheraVet_final.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport Financier Semestriel' (Interim Financial Report) for the period ending June 30, 2021. It contains detailed financial statements, a management report (Rapport d'activité), notes on financial performance, and an attestation from the management. It is a comprehensive report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-10-29 French
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is titled "Mise à disposition du rapport semestriel 2021" (Availability of the 2021 semi-annual report). It explicitly states that the company is announcing the publication and filing of its 'rapport semestriel au 30 juin 2021' (semi-annual report as of June 30, 2021) with regulatory bodies (FSMA and Euronext Growth®). The document itself is very short (2285 characters) and directs the reader to a website link to access the actual report. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or is available elsewhere classifies this document as a Report Publication Announcement (RPA). The content is not the comprehensive Interim Report (IR) itself, but the announcement of its release.
2021-10-29 French
CP_TheraVet_Information Règlementée_Article 15 loi belge du 02 mai 2007.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au Nombre Total de Droits de Vote et d'Actions (Article 15 de la loi du 02 mai 2007)" and explicitly publishes the total number of shares and voting rights as of October 26, 2021. This type of mandatory disclosure regarding the total voting rights and capital structure, often triggered by regulatory thresholds or specific legal articles (like Article 15 mentioned here, common in European markets), relates directly to shareholder structure and voting power. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit, as it covers official announcements related to voting rights and results, even if this specific filing is a periodic update rather than the final result of a specific vote. It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as DVA is more specific to this content.
2021-10-26 French
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au Nombre Total de Droits de Vote et d'Actions (Article 15 de la loi du 02 mai 2007)" and explicitly publishes the total number of shares and voting rights as of October 26, 2021. This type of mandatory disclosure regarding the total voting rights and capital structure, often triggered by regulatory thresholds or specific legal articles (like Article 15 mentioned here, common in European markets), relates directly to shareholder structure and voting power. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit, as it covers official announcements related to voting rights and results, even if this specific filing is a periodic update rather than the final result of a specific vote. It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as DVA is more specific to this content.
2021-10-26 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.